German regulator concludes audit of Dr Reddy’s Vishakapatnam facility

12 Nov 2018 Evaluate

The Regulatory Authority of Germany (Regierung von Oberbayern) has concluded the follow-on audit of Dr. Reddy’s Laboratories’ Formulations manufacturing facility in Duvvada, Vishakapatnam, on November 09, 2018. The facility is considered compliant and the EU-GMP certification continues to remain active with one specific exclusion of a new product. The company will be submitting a detailed Corrective and Preventive Action Plan (CAPA) to the authorities.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

5955.65 71.30 (1.21%)
28-May-2024 15:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1464.85
Dr. Reddys Lab 5955.65
Cipla 1477.15
Zydus Lifesciences 1050.35
Lupin 1603.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.